← Scoopfeeds — Intelligent news, curated.
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
top

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

The Guardian · Jun 18, 2026, 12:45 PM · Also reported by 2 other sources

Why this matters: a developing story that could shape the day's news cycle.

Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older US health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the Covid-19 pandemic. Moderna is seeking Food and Drug Administration (FDA) approv

Read full story on The Guardian → More top stories

Also covered by

The Hill FDA vaccine panel set to review Moderna mRNA flu shot Investing.com Trump administration asks appeals court to let Kennedy pick vaccine panel members

More in top

NPR News
Ukraine hits a Moscow oil refinery and other sites in a large-scale drone attack
NPR News
You're probably using too many skin care products. Here are the 3 essentials
BBC News
Man arrested on suspicion of attempted murder after boy injured in crocodile enclosure
The Guardian
Young men in UK are not more rightwing than older groups, study says
The Guardian
Fed governor Lisa Cook faced $1.3m in legal and security fees after Trump’s bid to fire her
Aggregated and edited by the Scoop newsroom. We surface news from The Guardian alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop